nafamostat has been researched along with 4-(2-aminoethyl)benzenesulfonylfluoride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Adler, G; Algül, H; Schmid, RM; Schneider, G; Tando, Y; Weber, CK; Weidenbach, H | 1 |
2 other study(ies) available for nafamostat and 4-(2-aminoethyl)benzenesulfonylfluoride
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Induction of IkappaB-kinase by cholecystokinin is mediated by trypsinogen activation in rat pancreatic lobules.
Topics: Animals; Benzamidines; Blotting, Western; Cholecystokinin; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme Induction; Guanidines; I-kappa B Kinase; In Vitro Techniques; Male; NF-kappa B; Pancreas; Precipitin Tests; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Sulfones; Trypsin Inhibitors; Trypsinogen; Tumor Necrosis Factor-alpha | 2002 |